# FDA Inspection 1177854 - Mitchell Horwitz, M.D. - August 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/9c6ae860-50a6-44e0-b0f2-ecab949fd205
Source feed: FDA_Inspections

> FDA Inspection 1177854 for Mitchell Horwitz, M.D. on August 19, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177854
- Company Name: Mitchell Horwitz, M.D.
- Inspection Date: 2022-08-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309210 - 2026-03-12](https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/0637a973-f02f-4406-a025-6f2c3b9c6870)
- [FDA Inspection 1309210 - 2026-03-12](https://www.keypedia.com/records/fda_inspections/mitchell-horwitz-md/e8a75aa3-671d-4456-9c64-324e81d91f88)

Company: https://www.keypedia.com/companies/mitchell-horwitz-md/e1c48c75-5581-4a10-b78c-11bcbc17ab53

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d